Altria Files Lawsuit Against FDA Over Tobacco Review Process

Tobacco giant Altria has initiated legal action against the U.S. Food and Drug Administration, arguing that the agency’s product review framework is fundamentally flawed and inconsistent. The lawsuit seeks judicial intervention to compel regulatory reforms that would streamline approval pathways for modified-risk products.